914 related articles for article (PubMed ID: 30735730)
21. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
Altundag-Erdogan O; Tutar R; Yüce E; Çelebi-Saltik B
Daru; 2024 May; ():. PubMed ID: 38722566
[TBL] [Abstract][Full Text] [Related]
22. Herbal pre-conditioning induces proliferation and delays senescence in Wharton's Jelly Mesenchymal Stem Cells.
Sanap A; Chandravanshi B; Shah T; Tillu G; Dhanushkodi A; Bhonde R; Joshi K
Biomed Pharmacother; 2017 Sep; 93():772-778. PubMed ID: 28724259
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/β-Catenin signaling in breast cancer.
Xie T; Jiang C; Dai T; Xu R; Zhou X; Su X; Zhao X
Mol Carcinog; 2019 Oct; 58(10):1832-1845. PubMed ID: 31219645
[TBL] [Abstract][Full Text] [Related]
24. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.
Zhang LN; Huang YH; Zhao L
Arch Biochem Biophys; 2019 Nov; 676():108137. PubMed ID: 31605677
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats.
Gao LR; Zhang NK; Zhang Y; Chen Y; Wang L; Zhu Y; Tang HH
Stem Cell Res Ther; 2018 Dec; 9(1):339. PubMed ID: 30526660
[TBL] [Abstract][Full Text] [Related]
26. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl
Baig MT; Ghufran H; Mehmood A; Azam M; Humayun S; Riazuddin S
Biochem Pharmacol; 2021 Apr; 186():114480. PubMed ID: 33617844
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators.
Bhuvanalakshmi G; Arfuso F; Kumar AP; Dharmarajan A; Warrier S
Stem Cell Res Ther; 2017 Aug; 8(1):185. PubMed ID: 28807014
[TBL] [Abstract][Full Text] [Related]
28. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
31. Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeads.
Penolazzi L; Tavanti E; Vecchiatini R; Lambertini E; Vesce F; Gambari R; Mazzitelli S; Mancuso F; Luca G; Nastruzzi C; Piva R
Tissue Eng Part C Methods; 2010 Feb; 16(1):141-55. PubMed ID: 19402785
[TBL] [Abstract][Full Text] [Related]
32. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
33. Single-cell RNA-seq highlights heterogeneity in human primary Wharton's jelly mesenchymal stem/stromal cells cultured in vitro.
Sun C; Wang L; Wang H; Huang T; Yao W; Li J; Zhang X
Stem Cell Res Ther; 2020 Apr; 11(1):149. PubMed ID: 32252818
[TBL] [Abstract][Full Text] [Related]
34. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.
Zhou X; Li T; Chen Y; Zhang N; Wang P; Liang Y; Long M; Liu H; Mao J; Liu Q; Sun X; Chen H
Int J Oncol; 2019 May; 54(5):1843-1852. PubMed ID: 30864702
[TBL] [Abstract][Full Text] [Related]
36. Effects of Wharton's jelly mesenchymal stem cells-derived secretome on colon carcinoma HT-29 cells.
Rezaei-Tazangi F; Alidadi H; Samimi A; Karimi S; Kahorsandi L
Tissue Cell; 2020 Dec; 67():101413. PubMed ID: 32835945
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
38. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells.
Behrens A; Jousheghany F; Yao-Borengasser A; Siegel ER; Kieber-Emmons T; Monzavi-Karbassi B
Pharmacology; 2020; 105(5-6):246-259. PubMed ID: 32344408
[TBL] [Abstract][Full Text] [Related]
40. Differentiation potential of different regions-derived same donor human Wharton's jelly mesenchymal stem cells into functional smooth muscle-like cells.
Bharti D; Shivakumar SB; Son YB; Choi YH; Ullah I; Lee HJ; Kim EJ; Ock SA; Park JE; Park JK; Kang D; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2019 Aug; 377(2):229-243. PubMed ID: 30945004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
